Skip to main content

Phoenix Holdings Ltd.

SEC CIK
0001679543
Latest filing
Aug 11, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by Phoenix Holdings Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
42,933,367
Value
$1.45B
% of portfolio
9.9%
Quarters held
22
Since Q1 2021
Holdings of TEVA by Phoenix Holdings Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202642,933,367$1.45B9.9%+155,953+0.4%AddedHolders
Q1 202642,777,414$1.29B12.2%+1,690,283+4.1%AddedHolders
Q4 202541,087,131$1.28B13.9%−208,113−0.5%ReducedHolders
Q3 202541,295,244$834.2M10.2%+3,533,800+9.4%AddedHolders
Q2 202537,761,444$632.9M8.3%+10,296,872+37.5%AddedHolders
Q1 202527,464,572$422.1M6.5%+6,252,030+29.5%AddedHolders
Q4 202421,212,542$467.5M6.5%−1,349,134−6.0%ReducedHolders
Q3 202422,561,676$406.6M6.0%−2,860,920−11.3%ReducedHolders
Q2 202425,422,596$413.1M6.3%−9,159,191−26.5%ReducedHolders
Q1 202434,581,787$488.1M6.7%+198,595+0.6%AddedHolders
Q4 202334,383,192$404.3M6.7%−98,500−0.3%ReducedHolders
Q3 202334,481,692$351.7M6.6%+778,282+2.3%AddedHolders
Q2 202333,703,410$253.8M5.3%+11,569,608+52.3%AddedHolders
Q1 202322,133,802$195.9M4.4%−24,749−0.1%ReducedHolders
Q4 202222,158,551$202.1M3.9%+1,327,471+6.4%AddedHolders
Q3 202220,831,080$162.9M3.6%+2,301,291+12.4%AddedHolders
Q2 202218,529,789$139.4M2.9%+1,830,388+11.0%AddedHolders
Q1 202216,699,401$156.8M2.7%+1,513,100+10.0%AddedHolders
Q4 202115,186,301$121.7M2.1%+1,015,500+7.2%AddedHolders
Q3 202114,170,801$138.1M2.5%+2,620,800+22.7%AddedHolders
Q2 202111,550,001$114.4M2.2%−26,132−0.2%ReducedHolders
Q1 202111,576,133$133.6M3.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.